drugset / Trial / NCT01114191
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This is a phase 1, open-label study designed to determine the interaction of ketoconazole with ABT-869.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-869 | Unknown | 17.5 mg | — |
| Subject | Ketoconazole | Small molecule | 400 mg | — |